This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tong, Z. Articles by Rainbow, A. J. Search for Related Content PubMed PubMed Citation Articles by Tong, Z. Articles by Rainbow, A. J.

Sustained Activation of the Extracellular Signal-regulated Kinase Pathway Protects Cells from Photofrin-mediated Photodynamic Therapy¹

Department of Biology, McMaster University, Hamilton, Ontario L8S 4K1 [Z. T., G. S., A. J. R.]; Hamilton Regional Cancer Center, Hamilton, Ontario L8V 5C2 [Z. T., G. S.]; and Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario L8S 4K1 [G. S.], Canada

Photodynamic therapy (PDT) is a cancer therapy in which a photosensitizer selectively accumulates in tumor cells and is subsequently activated by light of a specific wavelength. The activation of the photosensitizer leads to cytotoxic photoproducts that result in tumor regression. PDT can lead to several cellular responses including cell cycle arrest, necrosis, and apoptosis, as well as trigger many signaling pathways. It has been suggested that extracellular signal-activated protein kinases (ERKs), one subfamily of mitogen-activated protein kinases, play a crucial role in the cellular response to radiation therapy and chemotherapy. However, the role of ERKs in the cell survival after PDT is less clear. We have examined the response of the extracellular signal-regulated kinase ERK1/2 in PDT-resistant (LFS087) and PDT-sensitive (GM38A) cells after Photofrin-mediated PDT. ERK1/2 activity was induced rapidly in both cell types after PDT. The PDT-induced ERK1/2 activity was transient in GM38A cells and by 3 h had returned to a level significant lower than basal levels, whereas the induction of ERK1/2 was sustained in LFS087 cells and lasted for at least 11 h. Blocking of the sustained ERK activity with PD98059, an inhibitor of mitogen-activated protein/ERK kinase, significantly decreased cell survival of LFS087 after PDT. PDT also induced the expression of mitogen-activated protein kinase phosphatase, MKP-1, but reduced Raf-1 protein levels in both cell types. In GM38A cells, the substantially induced levels of MKP-1 correlated with the transient activation of ERK1/2 by PDT, and both basal and induced levels of MKP-1 were substantially greater in GM38 compared with Li Fraumeni syndrome cells. These observations suggest that sustained ERK1/2 activation protects cells from Photofrin-mediated phototoxicity and that the duration of ERK1/2 activation is regulated by MKP-1. In addition, the activation of ERK1/2 by Photofrin-mediated PDT is Raf-1 independent.

This article has been cited by other articles:

				H. L. Howie, S. L. Shiflett, and M. So Extracellular Signal-Regulated Kinase Activation by Neisseria gonorrhoeae Downregulates Epithelial Cell Proapoptotic Proteins Bad and Bim Infect. Immun., June 1, 2008; 76(6): 2715 - 2721. [Abstract] [Full Text] [PDF]

				A. Weyergang, O. Kaalhus, and K. Berg Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival Mol. Cancer Ther., June 1, 2008; 7(6): 1740 - 1750. [Abstract] [Full Text] [PDF]

				A. Ito, T. Suganami, Y. Miyamoto, Y. Yoshimasa, M. Takeya, Y. Kamei, and Y. Ogawa Role of MAPK Phosphatase-1 in the Induction of Monocyte Chemoattractant Protein-1 during the Course of Adipocyte Hypertrophy J. Biol. Chem., August 31, 2007; 282(35): 25445 - 25452. [Abstract] [Full Text] [PDF]

				K. A. Cengel, S. M. Hahn, and E. Glatstein C225 and PDT Combination Therapy for Ovarian Cancer: The Play's the Thing J Natl Cancer Inst, October 19, 2005; 97(20): 1488 - 1489. [Full Text] [PDF]

				M. G. del Carmen, I. Rizvi, Y. Chang, A. C. E. Moor, E. Oliva, M. Sherwood, B. Pogue, and T. Hasan Synergism of Epidermal Growth Factor Receptor-Targeted Immunotherapy With Photodynamic Treatment of Ovarian Cancer In Vivo J Natl Cancer Inst, October 19, 2005; 97(20): 1516 - 1524. [Abstract] [Full Text] [PDF]

				Y.-Y. He, J.-L. Huang, and C. F. Chignell Delayed and Sustained Activation of Extracellular Signal-regulated Kinase in Human Keratinocytes by UVA: IMPLICATIONS IN CARCINOGENESIS J. Biol. Chem., December 17, 2004; 279(51): 53867 - 53874. [Abstract] [Full Text] [PDF]

				T.-W. Wong, E. Tracy, A. R Oseroff, and H. Baumann Photodynamic Therapy Mediates Immediate Loss of Cellular Responsiveness to Cytokines and Growth Factors Cancer Res., July 1, 2003; 63(13): 3812 - 3818. [Abstract] [Full Text] [PDF]

				Y.-W. Lin, S.-M. Chuang, and J.-L. Yang ERK1/2 Achieves Sustained Activation by Stimulating MAPK Phosphatase-1 Degradation via the Ubiquitin-Proteasome Pathway J. Biol. Chem., June 6, 2003; 278(24): 21534 - 21541. [Abstract] [Full Text] [PDF]